M L McCarroll1, S Armbruster2, H E Frasure3, M D Gothard4, K M Gil2, M B Kavanagh5, S Waggoner3, V E von Gruenigen2. 1. Summa Health System, Akron, OH, USA. Electronic address: mccarrollm@summahealth.org. 2. Summa Health System, Akron, OH, USA. 3. Department of Obstetrics and Gynecology, University Hospitals, Case Western Reserve University, Cleveland, OH, USA. 4. Biostats Inc., Canton, OH, USA. 5. Department of Nutrition, Case Western Reserve University, Cleveland, OH, USA.
Abstract
OBJECTIVE: More patient-centered programming is essential for endometrial cancer (EC) survivors needing to lose weight to reduce cardiovascular disease risk (CVD). The purpose of this study was to improve self-efficacy (SE) and quality of life (QOL) using a lifestyle intervention program designed for weight loss. METHODS:Overweight and obese early-stage EC survivors, n = 75, were randomized into two groups: 1) Survivors of Uterine Cancer Empowered by Exercise and Healthy Diet (SUCCEED), a six-month lifestyle intervention or 2) a usual care group (UC). Participants completed the Weight Efficacy Lifestyle Questionnaire (WEL) to assess SE and the Functional Assessment of Cancer Therapy-General (FACT-G) to measure QOL, and their body mass index (BMI) was calculated at baseline, 3, 6, and 12 months. Mixed, repeated-measures ANCOVA models with baseline covariates were employed using SPSS 20.0. RESULTS: Positive effects in every WEL domain, including the total score, were statistically significant in the SUCCEED group versus the UC group. A linear regression model demonstrated that, if BMI decreased by 1 unit, the total WEL score increased by 4.49 points. Significant negative correlations were found in the total WEL score and a change in BMI of R = -0.356 (p = 0.006). Between-group differences in the FACT-G were significant from baseline in the fatigue domain at three months (p = .008) and in the physical domain at six months (p = .048). No other significant differences were found. CONCLUSION: Overall, this study shows promise for targeted interventions to help improve SE, thus improving BMI.
RCT Entities:
OBJECTIVE: More patient-centered programming is essential for endometrial cancer (EC) survivors needing to lose weight to reduce cardiovascular disease risk (CVD). The purpose of this study was to improve self-efficacy (SE) and quality of life (QOL) using a lifestyle intervention program designed for weight loss. METHODS: Overweight and obese early-stage EC survivors, n = 75, were randomized into two groups: 1) Survivors of Uterine Cancer Empowered by Exercise and Healthy Diet (SUCCEED), a six-month lifestyle intervention or 2) a usual care group (UC). Participants completed the Weight Efficacy Lifestyle Questionnaire (WEL) to assess SE and the Functional Assessment of Cancer Therapy-General (FACT-G) to measure QOL, and their body mass index (BMI) was calculated at baseline, 3, 6, and 12 months. Mixed, repeated-measures ANCOVA models with baseline covariates were employed using SPSS 20.0. RESULTS: Positive effects in every WEL domain, including the total score, were statistically significant in the SUCCEED group versus the UC group. A linear regression model demonstrated that, if BMI decreased by 1 unit, the total WEL score increased by 4.49 points. Significant negative correlations were found in the total WEL score and a change in BMI of R = -0.356 (p = 0.006). Between-group differences in the FACT-G were significant from baseline in the fatigue domain at three months (p = .008) and in the physical domain at six months (p = .048). No other significant differences were found. CONCLUSION: Overall, this study shows promise for targeted interventions to help improve SE, thus improving BMI.
Authors: Karen Basen-Engquist; Catherine M Alfano; Melissa Maitin-Shepard; Cynthia A Thomson; Kathryn H Schmitz; Bernardine M Pinto; Kevin Stein; David S Zucker; Karen L Syrjala; Elizabeth Fallon; Colleen Doyle; Wendy Demark-Wahnefried Journal: Obesity (Silver Spring) Date: 2017-11 Impact factor: 5.002
Authors: Brian D Gonzalez; Sharon L Manne; Jerod Stapleton; Shannon Myers-Virtue; Melissa Ozga; David Kissane; Carolyn Heckman; Mark Morgan Journal: Support Care Cancer Date: 2016-10-19 Impact factor: 3.603
Authors: Lorraine T Dean; Xiaochen Zhang; Nawar Latif; Robert Giuntoli; Lilie Lin; Ashley Haggerty; Sarah Kim; David Shalowitz; Caitlin Stashwick; Fiona Simpkins; Robert Burger; Mark Morgan; Emily Ko; Kathryn Schmitz Journal: Support Care Cancer Date: 2016-03-30 Impact factor: 3.603
Authors: Ashley F Haggerty; Sarah Huepenbecker; David B Sarwer; Jacqueline Spitzer; Greer Raggio; Christina S Chu; Emily Ko; Kelly C Allison Journal: Gynecol Oncol Date: 2015-11-28 Impact factor: 5.482
Authors: Angeles Alvarez Secord; Vic Hasselblad; Vivian E Von Gruenigen; Paola A Gehrig; Susan C Modesitt; Victoria Bae-Jump; Laura J Havrilesky Journal: Gynecol Oncol Date: 2015-10-31 Impact factor: 5.482